Status: Recruiting
Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
A 13-week multi-center single-arm trial, preceded by a 2-week standard therapy phase, will be conducted to assess the safety of MODI, an insulin titration algorithm, in adults with type 1 diabetes (T1D) who use multiple daily insulin injections (MDI), or with type 2 diabetes (T2D) who use MDI, basal insulin only, or who are candidates to initiate basal insulin, in conjunction with continuous glucose monitoring (CGM).
Participants needed: 102
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: DreaMed DiabetesUpdated: Jun 3, 2026Locations: 3
Eligibility criteria
Clinical diagnosis, based on investigator assessment, of T1D or T2D of at least... [+14]
Use of an insulin pump within 3 months prior to informed consent [+15]